PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33671709-7	2021	Furthermore, cell pretreatment with proteasome inhibitor MG132 completely abrogates the effect of Olaparib, suggesting that PARP1 acts with NF-kappaB in the same regulatory pathway, which controls pro-inflammatory cytokine transcription.	olaparib	98-106	nuclear factor kappa B subunit 1	Homo sapiens	140-149	
35130631-9	2022	Our results suggest that Olaparib attenuates the activity of the NF-kappaB pathway and decreases the DNA damage response induced by IDA.	olaparib	25-33	nuclear factor kappa B subunit 1	Homo sapiens	65-74	
32329510-6	2020	We further revealed that treatment of IRCs with CM together with Olaparib led to significantly lower mRNA expression levels and fluorescent intensities of NF-kappaB, while treatment of IRCs with CM together the NF-kappaB inhibitor BAY-11-7082 led to significantly lower mRNA expression levels as well as fluorescent intensities of PARP1.	olaparib	65-73	nuclear factor kappa B subunit 1	Homo sapiens	155-164